
The baby saved from a rare disease by a first-ever personalized gene fix has reached a big milestone, taking his first steps ahead of Christmas.
KJ Muldoon is walking and getting ready to celebrate the holiday season at home with his parents and three siblings.
KJ was born last year with a genetic disorder called carbamoyl-phosphate synthetase 1 deficiency. Also known as CPS1 deficiency, the metabolic condition affects only 1 in 1.3 million babies and often leads to life-threatening outcomes.
When he was 6 months old, doctors began giving KJ a groundbreaking new treatment -- a personalized CRISPR gene editing therapy at Children's Hospital of Philadelphia.
Doctors save baby's life with first-ever gene fix for deadly rare disease
The gene-editing therapy works like a "molecular spell-checker,” finding and fixing the specific genetic error causing his condition.
After three infusions and after spending the first 10 months of his life in a hospital, KJ was discharged and sent home in June.
Baby saved by gene-editing therapy 'graduates' from hospital, goes home
Since then, KJ has continued to grow and thrive with his family, celebrating his first birthday at home and taking part in one of the family’s favorite rituals -- cheering for their beloved Philadelphia Eagles.
Doctors hope new technology like CRISPR gene-editing therapies can be the key to treating more than 7,000 rare diseases, such as sickle cell disease, cystic fibrosis, Huntington’s disease and muscular dystrophy, that affect approximately 30 million people across the country.
LATEST POSTS
- 1
Council removes proposal to rename park named after former president of Israel - 2
Best Quest for new employment Site for You to Track down Amazing open doors - 3
Israel kidnaps PIJ terrorist in covert op. in Hamas-controlled Gaza in pursuit of Ran Gvili - 4
Huge Iranian missile fragments, intercepted by air defenses, lay scattered across Israel, West Bank - 5
10 Work Valuable chances to Assist with supporting Your Advanced degree
Top German court to rule on claims by Wirecard shareholders
Volkswagen in talks with defence firms on use of Germany plant: CEO
10 Fundamental Tips and Deceives to Lift Your Cell phone's Exhibition
Travel Through France's Most Iconic Wine Regions By Train On An Immersive Seven-Day Journey
Finding Your Motivation: Moves toward a Satisfying Life
Blue Origin launches New Glenn rocket on company's first NASA-scale science mission
Charlotte faith leaders hold interfaith forum on Black and Palestinian solidarity
10 times the sky amazed us in 2025
What you need to know about flu treatments as cases spike across the US












